| Financial Year |
March 31 2023 |
| Monetary Funds |
17,121,936,049.43 |
| Held-for-trading Financial Assets |
1,077,463,073.03 |
| Notes Receivable |
147,479,063.25 |
| Accounts Receivable |
32,729,481,981.75 |
| Advances to Suppliers |
3,027,568,280.29 |
| Other Receivables |
3,855,326,641.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
24,873,598.08 |
| Inventories |
11,560,205,993.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,504,704,660.02 |
| Total Current Assets |
75,251,000,819.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,805,855,763.79 |
| Investment Properties |
110,248,101.24 |
| Fixed Assetes |
114,666,176,684.45 |
| Under-construction Projects |
17,065,427,946.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,107,302,791.97 |
| R&D expenses |
7,786,878.10 |
| Goodwill |
26,496,074,736.60 |
| Long-Term Deferred and Prepaid Expenses |
5,128,901,474.58 |
| Deferred Income Tax Assets |
3,696,715,475.24 |
| Other Non-Current Assets |
1,721,257,265.68 |
| Sub-Total of Non-Current Assets |
221,423,283,015.64 |
| Total Assets |
296,674,283,835.38 |
| Short-Term Loans |
28,932,402,407.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,736,044,194.45 |
| Accounts Payable |
31,320,216,022.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
657,061,889.56 |
| Taxes Payable |
1,763,902,144.38 |
| Interest Payable |
-- |
| Dividend Payable |
962,559,668.30 |
| Other payables |
39,781,137,355.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,502,127,006.33 |
| Other Current Liabilities |
3,753,442,217.85 |
| Sub-Total of Current Liabilities |
133,325,389,728.10 |
| Long-term Loans |
49,093,815,524.74 |
| Bonds Payable |
9,516,688,270.44 |
| Long-Term Accounts Payable |
2,214,533,939.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,311,519,531.29 |
| Deferred Income Tax Liabilities |
2,115,926,537.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,305,598,542.57 |
| Total Liabilities |
200,630,988,270.67 |
| Paid-In Capital(Or Share Stock) |
8,663,422,814.00 |
| Capital Surplus |
33,945,789,780.06 |
| Surplus Reserve |
5,216,801,771.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
32,367,874,904.13 |
| Minority Stockholder's Interest |
15,308,961,386.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
80,734,334,177.78 |
| Owner's Equity（Stockholder's Equity） |
96,043,295,564.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
296,674,283,835.38 |
